USD 3.05
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 77.35 Thousand USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 125.45 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2002 | 6.53 Million USD | -45.66% |
2001 | 12.02 Million USD | 214.07% |
2000 | 3.83 Million USD | -5.85% |
1999 | 4.06 Million USD | 16.23% |
1998 | 3.5 Million USD | -33.71% |
1997 | 5.28 Million USD | 49.15% |
1996 | 3.54 Million USD | -23.04% |
1995 | 4.6 Million USD | -20.69% |
1994 | 5.8 Million USD | -21.62% |
1993 | 7.4 Million USD | 8.82% |
1992 | 6.8 Million USD | 172.0% |
1991 | 2.5 Million USD | 4.17% |
1990 | 2.4 Million USD | 14.29% |
1989 | 2.1 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 70.9 Thousand USD | -8.33% |
2024 Q2 | 64.39 Thousand USD | -9.19% |
2023 FY | 77.35 Thousand USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | 77.35 Thousand USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | -100.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | 125.45 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2003 Q1 | 6.04 Million USD | -7.48% |
2003 Q2 | 5.5 Million USD | -8.96% |
2003 Q3 | 4.8 Million USD | -12.81% |
2002 Q4 | 6.53 Million USD | -8.74% |
2002 Q1 | 9.22 Million USD | -23.35% |
2002 FY | 6.53 Million USD | -45.66% |
2002 Q2 | 7.67 Million USD | -16.8% |
2002 Q3 | 7.16 Million USD | -6.64% |
2001 FY | 12.02 Million USD | 214.07% |
2001 Q2 | 8.75 Million USD | 38.17% |
2001 Q3 | 10.71 Million USD | 22.45% |
2001 Q4 | 12.02 Million USD | 12.24% |
2001 Q1 | 6.33 Million USD | 65.38% |
2000 Q2 | 5.19 Million USD | 1.66% |
2000 Q4 | 3.83 Million USD | -23.17% |
2000 FY | 3.83 Million USD | -5.85% |
2000 Q1 | 5.11 Million USD | 25.66% |
2000 Q3 | 4.98 Million USD | -4.08% |
1999 Q3 | 4.3 Million USD | 0.0% |
1999 FY | 4.06 Million USD | 16.23% |
1999 Q4 | 4.06 Million USD | -5.4% |
1999 Q2 | 4.3 Million USD | 13.16% |
1999 Q1 | 3.8 Million USD | 8.57% |
1998 Q4 | 3.5 Million USD | -14.63% |
1998 FY | 3.5 Million USD | -33.71% |
1998 Q3 | 4.1 Million USD | -24.07% |
1998 Q2 | 5.4 Million USD | 20.0% |
1998 Q1 | 4.5 Million USD | -14.77% |
1997 Q3 | 5.4 Million USD | 14.89% |
1997 Q1 | 3.7 Million USD | 4.52% |
1997 FY | 5.28 Million USD | 49.15% |
1997 Q2 | 4.7 Million USD | 27.03% |
1997 Q4 | 5.28 Million USD | -2.22% |
1996 FY | 3.54 Million USD | -23.04% |
1996 Q2 | 6.1 Million USD | 22.0% |
1996 Q4 | 3.54 Million USD | -23.04% |
1996 Q3 | 4.6 Million USD | -24.59% |
1996 Q1 | 5 Million USD | 8.7% |
1995 FY | 4.6 Million USD | -20.69% |
1995 Q4 | 4.6 Million USD | -13.21% |
1995 Q1 | 5.2 Million USD | -10.34% |
1995 Q3 | 5.3 Million USD | 0.0% |
1994 Q4 | 5.8 Million USD | 11.54% |
1994 Q3 | 5.2 Million USD | 0.0% |
1994 Q1 | 7 Million USD | -5.41% |
1994 FY | 5.8 Million USD | -21.62% |
1993 FY | 7.4 Million USD | 8.82% |
1993 Q2 | 6.1 Million USD | 0.0% |
1993 Q3 | 6.2 Million USD | 1.64% |
1993 Q4 | 7.4 Million USD | 19.35% |
1992 Q4 | 6.8 Million USD | 0.0% |
1992 FY | 6.8 Million USD | 172.0% |
1991 FY | 2.5 Million USD | 4.17% |
1991 Q4 | 2.5 Million USD | 0.0% |
1990 Q4 | 2.4 Million USD | 0.0% |
1990 FY | 2.4 Million USD | 14.29% |
1989 FY | 2.1 Million USD | 0.0% |
1989 Q4 | 2.1 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | 96.547% |
Arrayit Corporation | 1.07 Million USD | 92.826% |
Atlantic International Corp. | 2.93 Million USD | 97.36% |
Biocept, Inc. | 12.1 Million USD | 99.361% |
Bioqual, Inc. | 3.58 Million USD | 97.844% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -6.526% |
DermTech, Inc. | 54.39 Million USD | 99.858% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.984% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 98.4% |
iMD Companies, Inc. | 1.12 Million USD | 93.094% |
IDenta Corp. | 789.14 Thousand USD | 90.198% |
Interpace Biosciences, Inc. | 11.19 Million USD | 99.309% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -76.424% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 99.038% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | 97.978% |
NovelStem International Corp. | 3.57 Million USD | 97.836% |
Optigenex Inc. | 8.94 Million USD | 99.135% |
Proteome Sciences plc | 17.15 Million USD | 99.549% |
Response Genetics, Inc | 6.37 Million USD | 98.786% |
Rennova Health, Inc. | 15.32 Million USD | 99.495% |
RushNet, Inc. | 4.82 Million USD | 98.396% |
ScreenPro Security Inc. | 207.03 Thousand USD | 62.638% |
Stella Diagnostics Inc. | 6.2 Million USD | 98.753% |
StageZero Life Sciences Ltd. | 1.8 Million USD | 95.703% |
Todos Medical Ltd. | 38.34 Million USD | 99.798% |